HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,453,211 | +20.5% | 324,707 | +13.3% | 1.28% | +27.0% |
| Q2 2023 | $10,333,694 | -6.3% | 286,490 | +0.3% | 1.00% | -9.2% |
| Q1 2023 | $11,028,310 | -32.6% | 285,722 | -0.3% | 1.11% | -33.8% |
| Q4 2022 | $16,367,967 | +30.6% | 286,523 | -9.2% | 1.67% | +19.5% |
| Q3 2022 | $12,529,000 | -5.0% | 315,584 | +5.3% | 1.40% | -1.5% |
| Q2 2022 | $13,192,000 | +58.2% | 299,825 | +33.3% | 1.42% | +66.0% |
| Q1 2022 | $8,338,000 | -26.5% | 224,849 | -19.5% | 0.86% | -24.7% |
| Q4 2021 | $11,338,000 | -4.0% | 279,423 | -3.8% | 1.14% | -4.6% |
| Q3 2021 | $11,813,000 | -6.1% | 290,394 | +4.9% | 1.19% | -2.5% |
| Q2 2021 | $12,575,000 | +12.2% | 276,912 | +3.0% | 1.22% | +4.7% |
| Q1 2021 | $11,211,000 | +8.7% | 268,917 | +11.4% | 1.17% | -10.5% |
| Q4 2020 | $10,309,000 | +32.8% | 241,362 | -17.5% | 1.30% | +32.9% |
| Q3 2020 | $7,761,000 | -1.0% | 292,570 | +0.9% | 0.98% | -3.9% |
| Q2 2020 | $7,840,000 | +53.2% | 290,087 | +2.1% | 1.02% | +20.8% |
| Q1 2020 | $5,118,000 | – | 284,143 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |